FeesSafety
Pluang+

Microbot Medical secures multiple new patents, boosting its global IP portfolio to 44 issued patents.

Company Fundamentals
20 Oct 2026, 15:30 WIB
GlobeNewsWire
View Source
Bullish
Microbot Medical secures multiple new patents, boosting its global IP portfolio to 44 issued patents.

Microbot Medical Inc. has been granted several new patents across the U.S., Japan, China, and Canada, increasing its total to 44 issued patents and 49 pending globally. This strengthens the company's intellectual property portfolio as it expands commercialization of its LIBERTY® Endovascular Robotic System in the U.S. and prepares for growth in international markets, including pursuing a CE Mark for the EU. The LIBERTY system is the only FDA-cleared, single-use robotic device for peripheral endovascular procedures, designed to improve precision and safety. The company views its robust patent estate as critical for supporting market expansion and monetizing its innovative technology.

Microbot Medical's expanding patent portfolio is notable amid today's Health-sector trading on Pluang. For readers following Health-sector US stocks, here is Pluang's market snapshot as of Oct 20, 2026 19:03 WIB: out of 150 priced stocks, 81 rose and 62 fell. XRAY (DENTSPLY SIRONA Inc) gained 4.99% to USD 8.84 with a typical hold time of 73 days, while ENVB (Enveric Biosciences Inc) dropped 4.96% to USD 1.34 with 100% sell order activity and a 14-day hold time. MMED (MiniMed Group Inc. Common Stock) declined 3.49% to USD 17.17 with a typical hold time of 11 days.

More News

Gorilla Technology posts record $69.5M Q3 revenue, targets $200M in 2026 amid AI infrastructure growth

Gorilla Technology posts record $69.5M Q3 revenue, targets $200M in 2026 amid AI infrastructure growth

Gorilla Technology reported a record $69.5 million in revenue for Q3 2026, driven by expanding AI infrastructure projects and hardware deliveries. The company reduced unbilled contract assets by over 50%, improving liquidity as it shifts focus from s...

Company Fundamentals
Bullish
32 minutes ago
Berkshire Hathaway holds steady on Apple shares despite 29% price rise and high valuation in 2026.

Berkshire Hathaway holds steady on Apple shares despite 29% price rise and high valuation in 2026.

Berkshire Hathaway has not sold any Apple shares in 2026, even as Apple's stock price rose 29% and its price-to-earnings ratio neared 40, indicating less concern about valuation. This decision reflects confidence in Apple's strong business fundamenta...

Market News
Bullish
36 minutes ago
US invests $1.6B to build domestic rare-earth supply chain with USA Rare Earth leading Texas mine development.

US invests $1.6B to build domestic rare-earth supply chain with USA Rare Earth leading Texas mine development.

The U.S. government is investing $1.6 billion to develop a domestic rare-earth supply chain, aiming to reduce reliance on China. USA Rare Earth is a key player, using the funds to build out mining and processing capabilities, including developing the...

Market News
Bullish
41 minutes ago
Alamar Biosciences raises 2026 revenue forecast to $121-$123M, driven by biopharma demand and clinical diagnostics expansion.

Alamar Biosciences raises 2026 revenue forecast to $121-$123M, driven by biopharma demand and clinical diagnostics expansion.

Alamar Biosciences increased its full-year 2026 revenue guidance to $121-$123 million, fueled by strong demand for consumables from biopharmaceutical clients who now represent 49% of Q3 revenue. The company’s NULISA platform was selected by the U.K. ...

Company Fundamentals
Bullish
41 minutes ago
CeriBell raises 2026 revenue forecast to $115-$117M, boosts hospital accounts and gross margin to 90%.

CeriBell raises 2026 revenue forecast to $115-$117M, boosts hospital accounts and gross margin to 90%.

CeriBell updated its full-year 2026 revenue guidance to $115 million to $117 million, driven by increased usage per hospital account and expansion by 35 new hospital accounts. The company improved its gross margin to 90% from 88% last year, supported...

Company Fundamentals
Bullish
41 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App